drugset / Trial / NCT06295796
A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this study is to evaluate the effect of moderate and severe renal impairment (RI) on the pharmacokinetics (PK), safety, and tolerability of MK-8527. There will be no hypothesis testing in the study.
Timeline
- Start
- 2024-06-20
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-8527 | Small molecule | — | Oral |